
Retatrutide 20 mg Starter
The Retatrutide 20 mg Starter puts one 20 mg Retatrutide vial, a 3 mL vial of bacteriostatic water and twenty graduated syringes in a single kit, packed in Australia by Australian Research Peptides for laboratories and researchers, ready to ship from stock. Its peptide, Retatrutide, is a 39-amino-acid chain studied in metabolic research and reported to bind the GIP, GLP-1 and glucagon receptors. Every item ships sealed, the Retatrutide vial is HPLC-tested, and the kit posts to every state and territory. Sold for in vitro research only.
Includes Retatrutide 20 mg + BAC Water 3 mL + 0.5 mL Graduated Syringes 20 Pack
Plus alcohol wipes, packed free with the syringes.
Free Express Post on any order with a bundle in it — the whole order, not just the bundle.
About Retatrutide 20 mg Starter
The Retatrutide 20 mg Starter is a three-item kit: one 20 mg Retatrutide vial, one 3 mL vial of bacteriostatic water and one pack of twenty graduated syringes, with alcohol wipes packed free beside them. No item is decanted, repackaged or mixed. Each arrives sealed exactly as it would on an order of its own, so the Starter is three listings bought together rather than a fourth product.
The three travel together because Retatrutide is supplied as a freeze-dried powder that needs BAC water as a diluent to dissolve it, and a graduated syringe to measure it. Leaving either off a first order holds the work up until a second parcel lands. The Starter carries the same 20 mg as the Retatrutide Value Bundle, in one vial instead of two.
Each component also keeps its own listing. Bacteriostatic water is sterile water preserved with 0.9% benzyl alcohol, and the syringes are standard graduated 0.5 mL units. The Retatrutide vial is HPLC-tested before release. The compound itself is covered below.
Retatrutide belongs to metabolic research. Eli Lilly developed it and has taken it from early studies into large late-stage trials. In laboratory receptor assays it acts at three receptors, GIP, GLP-1 and glucagon, which sets it apart from the GLP-1-only analogues and from the dual GIP/GLP-1 agonists.
Structurally it is a single chain of 39 amino acids built on a GIP peptide backbone, with a twenty-carbon fatty di-acid (C20) attached. That fatty group is described as binding albumin in the blood, the design feature reported to make the molecule long-acting.
Australian Research Peptides supplies the Starter's Retatrutide as a white to off-white freeze-dried solid in a sealed, tamper-evident glass vial. Researchers also write and search for it as reta or retat. It is a laboratory reference compound, intended for benchwork in glassware and cell culture, not for use in any living subject.
Content reviewed
Further reading: Where Is the Best Place to Buy Peptides in Australia?
Retatrutide 20 mg Starter specifications, storage and shipping
- Compound: Retatrutide 20 mg Starter
- Appearance: One vial of lyophilised powder, one vial of clear colourless solution, twenty capped syringes
- Sizes & SKUs: 20 mg vial + water + syringes (46426)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: High-purity research grade
- Purity verification: HPLC-assayed to a minimum of 99% purity before release
- Identity confirmation: Mass spectrometry
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
